Commercial insight into the pharma and biotech sector.
Interactive NPV Analyzer
Our Net Present Value (NPV) Analyzer is a powerful analytic tool with fully transparent valuations. With the NPV Analyzer there is no need to build complex spreadsheet models to value products - we provide the data and crunch the numbers - giving you a transparent and customizable valuation model ready for download.
EvaluatePharma offers the only online service with NPV Discounted Cash Flow models for 3500+ global products by Company and Therapy Area. Along with our innovative Calendar of Events tool we track and quantify the impact of key events on product and company valuation - from clinical trial results through to patent challenges and M&A.
- Fully transparent models for over 3,500 global products
- Complete flexibility to customize, save and download analyses
- Edit key assumptions for any product NPV including sales data, patent expiry, cost of capital and tax rate
- Model impact of major events on product valuation including patent extension, litigation and clinical trials
- Analyze impact of product value on both share price and market capitalization
Download the case study NPV Analyzer – A Powerful Tool for Quantitative Analysis, which looks at:
- Shire Pharmaceuticals: Vyvanse’s Growth Trajectory in the Face of Generic Threats
- Sanofi-Aventis: Market Reaction to Potential Safety Concerns for Lantus